Cyclo Therapeutics, Inc. Warrant
CYTHW
CYTHW was delisted on the 25th of March, 2025.
3 hedge funds and large institutions have $46.9K invested in Cyclo Therapeutics, Inc. Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
25% less funds holding
Funds holding: 4 → 3 (-1)
62% less capital invested
Capital invested by funds: $124K → $46.9K (-$77.1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$11.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$130K |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$1.87K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$467 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WVP
1
Worth Venture Partners
Fort Lee,
New Jersey
| $36.7K | -$1.87K | -3,166 | -4% |
|
|
2
Citadel Advisors
Miami,
Florida
| $10.1K | +$11.5K | +19,460 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $127 | -$467 | -792 | -76% |
|
|
ACM
4
AIGH Capital Management
Baltimore,
Maryland
| – | -$130K | -219,795 | Closed |
|
CYTHW Hedge Fund Activity: Q4 2022 in Review
3 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q4 2022, worth a combined $46.9K — down 62% from $124K a quarter earlier.
Fund positioning in CYTHW was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $11.5K. The largest seller was AIGH Capital Management, exiting entirely with an estimated $130K sold.
- 3 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q4 2022, down from 4 in Q3 2022.
- Funds reported $46.9K of Cyclo Therapeutics, Inc. Warrant stock for Q4 2022, down 62% quarter-over-quarter.
- 1 fund opened new Cyclo Therapeutics, Inc. Warrant positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest Cyclo Therapeutics, Inc. Warrant buyer in Q4 2022 was Citadel Advisors, an estimated $11.5K added.
- The largest Cyclo Therapeutics, Inc. Warrant seller in Q4 2022 was AIGH Capital Management, an estimated $130K sold.
Based on aggregated 13F filings for Q4 2022.